Front Page VSPN Message Boards Chat Library Continual Education Search MyVSPN - Coming Soon Help Frequently Asked Questions Send us Feedback! Go to VIN Industry Partners Go to VetQuest Go to Veterinary Partner Go to Y2Spay
 
Menu bar   Go to the VIN.com Portal
 

ABSTRACT OF THE WEEK

Journal of the American Veterinary Medical Association
Volume 243 | Issue 10 (November 2013)

Long-term outcome of sudden acquired retinal degeneration syndrome in dogs.

J Am Vet Med Assoc. November 2013;243(10):1425-31.
Jane A Stuckey1, Jacqueline W Pearce, Elizabeth A Giuliano, Leah A Cohn, Ellison Bentley, Amy J Rankin, Margi A Gilmour, Christine C Lim, Rachel A Allbaugh, Cecil P Moore, Richard W Madsen
1 Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506.

Abstract

OBJECTIVE: To investigate long-term outcomes and owner-perceived quality of life associated with sudden acquired retinal degeneration syndrome (SARDS) in dogs.

DESIGN: Survey study. Animals-100 dogs with SARDS examined at 5 academic veterinary institutions from 2005 to 2010.

PROCEDURES:The diagnosis was based on documented acute vision loss, normal results of ophthalmic examinations, and evaluation of extinguished bright-flash electroretinograms. Primary owners of affected dogs completed a questionnaire addressing outcome measures including vision, systemic signs, and perceived quality of life for their dogs.

RESULTS: Age at diagnosis was significantly correlated with positive outcome measures; dogs in which SARDS was diagnosed at a younger age were more likely to have alleged partial vision and higher owner-perceived quality of life. Polyphagia was the only associated systemic sign found to increase in severity over time. Medical treatment was attempted in 22% of dogs; visual improvement was not detected in any. Thirty-seven percent of respondents reported an improved relationship with their dog after diagnosis, and 95% indicated they would discourage euthanasia of dogs with SARDS.

CONCLUSIONS AND CLINICAL RELEVANCE: Blindness and concurrent systemic signs associated with SARDS appeared to persist indefinitely, but only polyphagia increased in severity over time. Most owners believed their pets had good quality of life and would discourage euthanasia of dogs with SARDS.

Companion Notes

Survey on the long-term outcome of sudden acquired retinal degeneration syndrome (SARDS) in 100 dogs

 

Study design

- introduction on sudden acquired retinal degeneration syndrome in the dog

- diagnosis based on the following:

- sudden vision loss

- normal fundus appearance

- nonrecordable electroretinogram

- results in permanent blindness (no known consistently effective treatment)

- unknown etiology

- median age of affected dogs: 8.5 years of age

- females account for ~ 60% of affected dogs

- consistently overrepresented breeds include the following:

- dachshund

- miniature schnauzer

- mixed-breed dogs

- up to 40% of SARDS dogs have concurrent systemic signs

- these are noted weeks to months before or soon after diagnosis

- polyuria/polydipsia

- polyphagia

- weight gain

- systemic signs are similar to the signs of hyperadrenocorticism

- nevertheless disorder has been diagnosed in only a few SARDS dogs

- biochemistry is also similar to that of hyperadrenocorticism and may include:

- hypercholesterolemia

- increased aspartate transaminase

- increased alanine transaminase

- increased corticosteroid­-induced isoenzyme of alkaline phosphatase

- inconsistently seen parameters include the following:

- stress leukogram

- thrombocytosis

- isosthenuria

- proteinuria

- systemic hypertension

- study population:

- 100 dogs with SARDS seen at 5 academic institutions from 05-10

- diagnosis based on the following:

- documented acute vision loss

- normal ophthalmic examinations

- extinguished bright-flash electroretinography

- 46 were alive and 54 were deceased

- 10 of the 39 dogs euthanized were euthanized due to SARDS

- female, 60% of the dogs

- mean age at diagnosis: 8.2 ± 2.2 years of age with a range of 4-16 years

- breeds representing 5% or more of sample population:

- mixed breed, 17

- dachs­hund, 15

- miniature schnauzer, 9

- pug, 7

- Brittany spaniel, 6

- bichon frise, 5

- maltese, 5

- clinical signs (16% of dogs had no clinical signs besides blindness)

- 42% of the dogs had all 4 signs below

- weight gain, 75%

- polyphagia, 69%

- polydipsia, 58%

- polyuria, 52%

- procedure:

- primary owners of affected dogs completed a questionnaire

 

Results

- 95% indicated they would discourage euthanasia of affected dogs

- age at diagnosis significantly correlated with positive outcome measures

- affected dogs diagnosed at a younger age more likely to have the following:

- alleged partial vision (45% reported pets had partial vision at times)

- higher owner-perceived quality of life

- 1 systemic sign was found to increase in severity over time: polyphagia

- medical treatment attempted in 22% of dogs

- no visual improvement detected in any dog by their owners

- corticosteroids, 13 dogs

- nutritional sup­plements, 3

- melatonin, 2

- doxycycline, 2

- 37% of respon­dents felt their relationship with their dog improved after diagnosis

- after diagnosis owners were significantly more likely to report dogs were more:

(as compared with reporting dogs were reclusive or seemed un­comfortable)

- cautious

- played less

- slept more

- seemed to have more signs of depression

- 87% reported dog had moderate to excel­lent scores for navigation ability in house

- 81% reported dog had moderate to excel­lent scores for navigation ability in yard

- 48% did not make special provisions for their blind dog

- 28% provided baby gates; 11% built fences and 5% used restraints like cages

- 4% built ramps to assist with stairs

- 3% taught dogs verbal com­mands to alert them to changes in topography

- 2% provided carpeted pathways to important locations

- 2% provided auditory clues or scents to signify certain locations

 

“Results of the present study sug­gested that dogs with SARDS were con­sidered by their owners to have a good to excellent quality of life.”

 

 

Article Tools:
   Medline
   Email to me

Archives Highlights:
How to plan and provide general anesthesia for a troop of 98 hamadryas baboons (Papio hamadryas) for contraceptive and preventative health interventions.
A group of 12 veterinarians, 2 zookeepers, and 6 volunteers anesthetized all animals within 2 days. The baboons were orally premedicated with midazolam (0.1 to 0.5 mg/kg) and anesthetized with medetomidine (40 to 60 µg/kg, IM) and ketamine (2 to 4 mg/kg, IM); isoflurane at rates of 1.5% to 2% was used for maintaining anesthesia if necessary. For population management, the animals received a contraceptive implant (adult females), orchiectomy (young males), or vasectomy (breeding males).
The Most Common Environmental Risk Factors for Equine Asthma-A Narrative Review.
The symptoms of equine asthma are typical of respiratory inflammations, and they include coughing, nasal discharge, and breathing difficulty even at rest in horses with severe asthma. BALF and tracheal wash analyses are the most popular methods of diagnosing equine asthma. Inadequate housing conditions undoubtedly increase the risk of asthma.
Prevalence of discospondylitis and association with congenital vertebral body malformations in English and French bulldogs.
The prevalence of discospondylitis was 3.4 (1.6-6.7) times higher in French bulldogs and 4.3 (1.7-9.8) times higher in English bulldogs, compared with the overall hospital cohort. One or more vertebral malformations were present in 12 French bulldogs (92.3%), 6 English bulldogs (75.0%), and 1 "other" breed dog (1.1%). Discospondylitis was diagnosed adjacent to congenital vertebral body malformations in 12 (80%) intervertebral discs in French bulldogs and 5 (50%) intervertebral discs in English bulldogs.
Feline acute patient physiologic and laboratory evaluation scores and other prognostic factors in cats with first-time diabetic ketoacidosis.
Median BG was significantly higher in non-survivors (431 mg/dL) compared with survivors (343 mg/dL) and BG predicted mortality. For every 1 mg/dL increase in BG, the odds of death increased by 1.004.
Case series of maggot debridement therapy demonstrates safety and efficacy for treating problematic wounds in cats and dogs in Mexico.
Treatment was administered by applying 8-10 larvae per square cm surface area directly on the wound bed and covering the wound with a sterile polyester mesh, sutured to the skin. These were left on the wound for cycles of approximately 48 hours (24-72 hours); the cycles were repeated if more than 20% necrotic tissue remained after treatment. Review of these cases revealed that 80% of treated wounds achieved 100% debridement within 48-96 hours of treatment.

Back Print Save Bookmark in my Browser Email this article to me. Top of Page. VSPN AOW : Long-term outcome of sudd...
Contact Us